Home
"There is no market in the world with greater potential, greater expectations, and greater risk aversity for biopharmaceutical firms than China. Clinical research activities in the Asia Pacific region cannot be successful without unlocking the barriers to entry in China"
Matthew Bryant, Senior Manager for Oncology Trials in Asia Pacific at DCOE AP-Eli Lilly Japan K.K. |
    |
|
4th Annual Partnerships in Clinical Trials Asia: The premier event for global and regional clinical leaders to build effective partnerships, improve quality management, and advance next practices in clinical trials in Asia.  Now in its fourth year, Partnerships in Clinical Trials Asia is delighted to return to China with an even more impressive speaker line up with representation from leading minds in China, Japan, India, US, EU, Singapore, Thailand, Indonesia, Korea, and Sri Lanka and a comprehensive program that looks at new ways to improve clinical operations and strategic partnering in Asia to improve quality, increase productivity and speed to market, and accelerate the progress of trials in the region. The 2012 event is currently in production, if you are interested in speaking, please contact Elle Quan at Elle.quan@ibcasia.com.sg or Danya Burakoff at dburakoff@iirusa.com |
Event Partners
.jpg "Clinical Research Centre")
.jpg "PAREXEL")
